当前位置:首页 - 行情中心 - 迈威生物-U(688062) - 财务分析 - 现金流量表

迈威生物-U

(688062)

  

流通市值:40.55亿  总市值:79.36亿
流通股本:2.04亿   总股本:4.00亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金55,090,410.77222,438,243.27180,722,393.45103,554,346.07
收到的税费返还-1,001,103.89--
收到其他与经营活动有关的现金4,291,650.04141,624,254.02118,419,345.9107,524,021.56
经营活动现金流入的平衡项目0000
经营活动现金流入小计59,382,060.81365,063,601.18299,141,739.35211,078,367.63
购买商品、接受劳务支付的现金1,576,538.6729,069,018.521,922,867.511,962,290.44
支付给职工以及为职工支付的现金109,071,015.94468,090,653.05365,179,181.34262,792,367.43
支付的各项税费6,362,782.4421,977,121.1918,699,340.9912,289,519.43
支付其他与经营活动有关的现金158,988,464.93802,370,438.62561,561,140.58385,657,961.81
经营活动现金流出的平衡项目0000
经营活动现金流出小计275,998,801.981,321,507,231.36967,362,530.41672,702,139.11
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-216,616,741.17-956,443,630.18-668,220,791.06-461,623,771.48
二、投资活动产生的现金流量:
收回投资收到的现金31,873,582.18382,459,886.99319,656,518.58246,636,335.21
取得投资收益收到的现金282,196.272,987,529.872,402,898.441,840,886.43
投资活动现金流入的平衡项目0000
投资活动现金流入小计32,155,778.45385,447,416.86322,059,417.02248,477,221.64
购建固定资产、无形资产和其他长期资产支付的现金35,441,639.18330,068,047.25226,460,591.16167,759,067.22
投资支付的现金42,387,334.98346,933,530.18290,908,037.57220,608,291.83
取得子公司及其他营业单位支付的现金9,304,163.76-7,863,248.662,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计87,133,137.92677,001,577.43525,231,877.39390,367,359.05
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-54,977,359.47-291,554,160.57-203,172,460.37-141,890,137.41
三、筹资活动产生的现金流量:
取得借款收到的现金651,840,0003,605,480,873.492,239,740,873.492,065,940,873.49
收到其他与筹资活动有关的现金100,000,0002,892,417.22,892,417.22,892,417.2
筹资活动现金流入平衡项目0000
筹资活动现金流入小计751,840,0003,608,373,290.692,242,633,290.692,068,833,290.69
偿还债务支付的现金533,172,555.632,669,130,225.011,343,537,169.381,324,580,873.49
分配股利、利润或偿付利息支付的现金23,155,253.166,111,902.5244,771,259.3630,222,358.28
支付其他与筹资活动有关的现金14,379,662.2941,433,330.9427,190,464.5317,377,260.5
筹资活动现金流出平衡项目0000
筹资活动现金流出小计570,707,471.022,776,675,458.471,415,498,893.271,372,180,492.27
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额181,132,528.98831,697,832.22827,134,397.42696,652,798.42
四、汇率变动对现金及现金等价物的影响-138,837.15232,889-933,514.53225,233.99
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-90,600,408.81-416,067,069.53-45,192,368.5493,364,123.52
加:期初现金及现金等价物余额1,227,566,165.231,643,633,234.761,643,633,234.761,643,633,234.76
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,136,965,756.421,227,566,165.231,598,440,866.221,736,997,358.28
补充资料:
净利润--1,046,564,705.48--446,245,025.76
资产减值准备-5,526,750.78-7,355,098.67
固定资产和投资性房地产折旧-93,556,473.38-43,433,403.21
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-93,556,473.38-43,433,403.21
无形资产摊销-18,800,120.51-9,801,134.88
长期待摊费用摊销-1,503,622.62-809,940.31
递延收益摊销-16,481,698.53-3,231,000
固定资产报废损失-113,812.15--
公允价值变动损失--493,457.59--179,946.72
财务费用-58,526,661.97-26,446,429.97
投资损失-4,218,903.47-1,737,207.91
递延所得税-0-0
其中:递延所得税资产减少-6,845,605.13-2,539,799.72
递延所得税负债增加--6,845,605.13--2,539,799.72
存货的减少--57,909,335.94--21,300,318.73
经营性应收项目的减少--77,362,611.67-11,952,123.9
经营性应付项目的增加--36,242,173.54--141,300,805.3
现金的期末余额-1,191,693,931.96-1,694,461,044.21
减:现金的期初余额-1,643,633,234.76-1,643,633,234.76
加:现金等价物的期末余额-35,872,233.27-42,536,314.07
公告日期2025-04-292025-03-312024-10-312024-08-31
审计意见(境内)标准无保留意见
TOP↑